Alice Chen

Q: What is Alice Chen email address?

Email Alice Chen at aliceye.chen@bms.com. This email is the most updated Alice Chen email found in 2026.

Q: How to contact Alice Chen?

To contact Alice Chen send an email to aliceye.chen@bms.com. If you want to call Alice Chen try calling on +16098184314. (updated on September 13, 2024)

Principal Scientist at Bristol Myers Squibb | Princeton, New Jersey, United States

About Alice Chen

Alice Chen is a distinguished Principal Scientist at Bristol Myers Squibb, where she leverages over two decades of expertise in drug research and development to spearhead innovative projects targeting atherosclerosis and cardiovascular diseases. Her extensive background in molecular and cell biology, biochemistry, and genetics positions her as a key contributor to the advancement of preclinical drug candidates, guiding them through the rigorous transition to clinical development.

In her current role, Alice is deeply involved in conducting in vitro pharmacology studies that are critical for understanding the mechanisms of action of potential therapeutics. Her proficiency in assay development is complemented by her hands-on experience with advanced techniques such as Western blotting, Taqman assays, and molecular cloning, enabling her to dissect complex biological pathways with precision. Alice's innovative approach is further exemplified by her work with transgenic mice, where she employs animal surgery and microinjection techniques to model human diseases and evaluate the efficacy of novel drug candidates.

Alice’s commitment to advancing cardiovascular therapeutics is evident in her collaborative efforts across multidisciplinary teams, where she integrates her knowledge of immunology and T cell biology to explore new avenues for treatment. Her high creativity and proven success rates in drug discovery not only drive her projects forward but also inspire her colleagues, making her a vital asset to Bristol Myers Squibb’s mission of delivering transformative medicines. Through her leadership and expertise, Alice Chen continues to shape the future of cardiovascular disease management, contributing to the development of therapies that hold the potential to significantly improve patient outcomes.

Alice Chen Work